z-logo
open-access-imgOpen Access
Choosing a Second Biologic Agent for Inflammatory Bowel Disease Patients—Cost Considerations and Clinical Outcomes
Author(s) -
Kofi Clarke
Publication year - 2020
Publication title -
crohn s and colitis 360
Language(s) - English
Resource type - Journals
ISSN - 2631-827X
DOI - 10.1093/crocol/otaa032
Subject(s) - inflammatory bowel disease , medicine , intensive care medicine , biologic agents , inflammatory bowel diseases , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom